Louis Hammerman
Internal Medicine · Boonton, NJNPI 1194724310
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,623 of the $3,829 with a category attached, or 68.5%. 20 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 46.0% of the total. Reporting peaked in 2021 at $2,545 and has fallen 88.9% since, to $283 in 2022.
Across 106 payments — averaging $36.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$2K
- Amgen$620
- AstraZeneca$438
- Novo Nordisk$193
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$188
- Biohaven Pharmaceutical Holding Company Ltd.$168
- plus $461 from 14 others
What the payments were for
- Consulting fees$1,20031%
- Food & beverage$2,62369%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 16 | $1,762 |
| Amgen | 28 | $620 |
| AstraZeneca | 9 | $438 |
| Novo Nordisk | 8 | $193 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $188 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $168 |
| Lilly USA, LLC | 7 | $94 |
| AbbVie(2 entities) | 5 | $66 |
| Pfizer | 4 | $53 |
| Boehringer Ingelheim | 4 | $52 |
| Biogen | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Bausch Health US, LLC | 1 | $21 |
| Astellas Pharma US Inc | 1 | $15 |
| GSK | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Abbott | 1 | $13 |
| Novartis | 1 | $12 |
| IBSA Pharma Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$1,553
- FARXIGA$248
- TRULANCE$123
- Otezla$123
- AIMOVIG$120
- BREZTRI$118
- Xultophy 100/3.6$114
How this compares
$3,829 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 11 | $251 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Boonton
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.